314 related articles for article (PubMed ID: 17968945)
1. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.
Tzelepis GE; Kelekis NL; Plastiras SC; Mitseas P; Economopoulos N; Kampolis C; Gialafos EJ; Moyssakis I; Moutsopoulos HM
Arthritis Rheum; 2007 Nov; 56(11):3827-36. PubMed ID: 17968945
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.
Kobayashi H; Yokoe I; Hirano M; Nakamura T; Nakajima Y; Fontaine KR; Giles JT; Kobayashi Y
J Rheumatol; 2009 Jan; 36(1):106-12. PubMed ID: 19040307
[TBL] [Abstract][Full Text] [Related]
3. Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging.
Nassenstein K; Breuckmann F; Huger M; Ladd SC; Schlosser T; Kreuter A; Barkhausen J
Rofo; 2008 Dec; 180(12):1054-60. PubMed ID: 19009498
[TBL] [Abstract][Full Text] [Related]
4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
5. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity.
Nucifora G; Aquaro GD; Pingitore A; Masci PG; Lombardi M
Eur J Heart Fail; 2011 Feb; 13(2):170-6. PubMed ID: 21208941
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
8. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).
Di Cesare E; Battisti S; Di Sibio A; Cipriani P; Giacomelli R; Liakouli V; Ruscitti P; Masciocchi C
Eur J Radiol; 2013 Jun; 82(6):e268-73. PubMed ID: 23510727
[TBL] [Abstract][Full Text] [Related]
9. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias.
Yiu KH; Schouffoer AA; Marsan NA; Ninaber MK; Stolk J; Vlieland TV; Scherptong RW; Delgado V; Holman ER; Tse HF; Huizinga TW; Bax JJ; Schuerwegh AJ
Arthritis Rheum; 2011 Dec; 63(12):3969-78. PubMed ID: 22127711
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis].
Wranicz JK; Strzondała M; Zielińska M; Cygankiewicz I; Ruta J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A
Przegl Lek; 2000; 57(7-8):389-92. PubMed ID: 11109311
[TBL] [Abstract][Full Text] [Related]
12. [Association between delayed enhancement on cardiac magnetic resonance imaging and arrhythmia in patients with hypertrophic cardiomyopathy].
WANG J; KONG XQ; XU HB; ZHOU GF; LIU F; SHI HJ; LIU DX
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):775-80. PubMed ID: 21092642
[TBL] [Abstract][Full Text] [Related]
13. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
Takase B; Nagata M
Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.
Romero-Puche A; Marín F; González-Carrillo J; García-Honrubia A; Climent V; Feliu E; Ruiz-Espejo F; Payá E; Gimeno-Blanes JR; de la Morena G; Valdés-Chavarri M
Rev Esp Cardiol; 2008 Aug; 61(8):853-60. PubMed ID: 18684368
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
Iles L; Pfluger H; Phrommintikul A; Cherayath J; Aksit P; Gupta SN; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2008 Nov; 52(19):1574-80. PubMed ID: 19007595
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions.
Hartke LP; Gilkeson RC; O'Riordan MA; Siwik ES
Congenit Heart Dis; 2006 Sep; 1(5):192-201. PubMed ID: 18377526
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis.
Muresan L; Oancea I; Mada RO; Petcu A; Pamfil C; Muresan C; Rinzis M; Pop D; Zdrenghea D; Rednic S
J Clin Rheumatol; 2018 Jan; 24(1):25-33. PubMed ID: 29200022
[TBL] [Abstract][Full Text] [Related]
19. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
[TBL] [Abstract][Full Text] [Related]
20. Primary myocardial involvement in systemic sclerosis.
Kahan A; Allanore Y
Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
